cariprazine news

All news on cariprazine (also known as Vraylar and Reagila): plants, production capacities, investments and involved companies.

4 May 2026

Johnson & Johnson: CAPLYTA tops adjunctive MDD antipsychotics in network meta-analysis

Network meta-analysis of 10 trials found an adjunctive atypical antipsychotic superior on MADRS change, response, remission and CGI‑S, with no significant weight gain and favorable tolerability.

Who will be producing cariprazine in the future?

Find out with chemXplore Alpha

Learn more